Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,868 | -25,445 | -76,180 | -47,802 | -27,871 |
| Depreciation Amortization | 4,236 | 2,008 | 6,077 | 4,267 | 2,748 |
| Accounts receivable | -11 | 236 | 10,860 | 10,288 | 9,455 |
| Other Working Capital | -4,890 | -3,056 | 12,017 | 2,276 | 5,682 |
| Other Operating Activity | 890 | 203 | -10,094 | -8,695 | -7,789 |
| Operating Cash Flow | $-55,643 | $-26,054 | $-57,320 | $-39,666 | $-17,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -112,672 | -82,927 | -67,162 | -43,555 | -23,834 |
| PPE Investments | -10,881 | -4,000 | -8,223 | -5,623 | -3,856 |
| Investing Cash Flow | $-123,553 | $-86,927 | $-75,385 | $-49,178 | $-27,690 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 192,703 | N/A | N/A |
| Debt Repayment | -252 | -111 | -572 | -462 | -331 |
| Common Stock Issued | 1,429 | 1,168 | 158,522 | 158,352 | 157,806 |
| Other Financing Activity | 0 | 0 | -1,533 | -50 | -33 |
| Financing Cash Flow | $1,177 | $1,057 | $349,120 | $157,840 | $157,442 |
| Beginning Cash Position | 247,393 | 247,393 | 30,978 | 30,978 | 30,978 |
| End Cash Position | 69,374 | 135,469 | 247,393 | 99,974 | 142,955 |
| Net Cash Flow | $-178,019 | $-111,924 | $216,415 | $68,996 | $111,977 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,643 | -26,054 | -57,320 | -39,666 | -17,775 |
| Capital Expenditure | -10,881 | -4,000 | -8,223 | -5,623 | -3,856 |
| Free Cash Flow | -66,524 | -30,054 | -65,543 | -45,289 | -21,631 |